Efficacy and Safety of CPX-351 versus 7+3 in Older Adults with Newly Diagnosed, Therapy-Related Acute Myeloid Leukemia (tAML): Subgroup Analysis of a Phase 3 Study
Autor: | Harry P. Erba, Michael Chiarella, Robert J. Ryan, Scott D. Solomon, Geoffrey L. Uy, Arthur C. Louie, Robert K. Stuart, Jonathan E. Kolitz, David A. Rizzieri, Jorge E. Cortes, Gary J. Schiller, Laura F. Newell, Jeffrey E. Lancet |
---|---|
Rok vydání: | 2017 |
Předmět: |
Oncology
Cancer Research medicine.medical_specialty business.industry Phases of clinical research Subgroup analysis Hematology Newly diagnosed Therapy-Related Acute Myeloid Leukemia 03 medical and health sciences 0302 clinical medicine 030220 oncology & carcinogenesis Internal medicine medicine business 030217 neurology & neurosurgery |
Zdroj: | Clinical Lymphoma Myeloma and Leukemia. 17:S288 |
ISSN: | 2152-2650 |
Databáze: | OpenAIRE |
Externí odkaz: |